Abstract
Non-invasive assessment of disease activity in patients with non-alcoholic (NALD) and alcoholic liver disease (ALD) is still unsettled but essential for the evaluation of disease progression. Total (M65) and caspase-cleaved (M30) serum cytokeratin-18 fragments are detectable in the serum and could give new insights into the role of …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
